The U.S. Food and Drug Administration (FDA) has set a date for next year by which it will decide whether or not to approve a…
News
July 15 marks the eighth annual Glioblastoma Awareness Day in the U.S., and advocates are calling for continued efforts to advance research and improve life…
The U.S. Food and Drug Administration (FDA) has approved a new version of Sarclisa (isatuximab), an approved treatment for multiple myeloma sold by…
Regulatory authorities in two countries have given the green light for clinical testing of a novel treatment from Mabwell Bioscience — which the company…
A new arm of a clinical trial has begun testing Knoa Pharma‘s experimental therapy tinostamustine in people with glioblastoma, an aggressive form of…
A protein called IRF2 may help drive myeloma, and measuring its levels could help predict outcomes among people with the blood cancer, a new…
U.S. authorities have granted a permanent billing code for Blenrep (belantamab mafodotin), an approved treatment for certain adults with hard-to-treat multiple myeloma., a…
A $16 million research initiative is bringing together scientists from six U.S. cancer centers to build on recent breakthroughs in targeted therapies and develop longer-lasting…
A regulatory committee in the European Union has recommended expanding approval of a dual regimen for hard-to-treat myeloma —…
A European Medicines Agency (EMA) committee is recommending expanded approval for Jaypirca (pirtobrutinib), an oral therapy used to treat chronic lymphocytic leukemia (CLL), a type…
